MAPT and Alzheimer disease: Accumulation of Aβ is a key early pathophysiological event in AD, leading to neurodegeneration and cognitive impairment by inducing abnormal accumulation of tau protein (Walsh and DJ, 2007; Selkoe and J, 2016).